Quince Therapeutics, Inc.
Quince Therapeutics, Inc. is a registered legal entity registered in United States under 5173483, and its current status with California Secretary of State — bizfile Online is inactive. The company was incorporated on 26 July 2022 and lists its registered address as United States. 3 shareholders are on record for Quince Therapeutics, Inc., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 6 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
3
Three shareholders are currently on record for Quince Therapeutics, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Vanguard Group Inc, holding 16.9% — the largest recorded stake — followed by Adar1 Capital Management, LLC at 1.2%; the remaining 1 shareholder shown holds smaller stakes.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 16.9% | California Secretary of State — bizfile Online | |
| Adar1 Capital Management, LLC | 1.2% | California Secretary of State — bizfile Online | |
| iShares Trust-iShares Micro-Cap ETF | 0.7% | California Secretary of State — bizfile Online |
Officers
5
The Ceo, Chief Medical Officer & Director of Quince Therapeutics, Inc. currently on record is Dirk Thye M.d.; five officers are currently on record for Quince Therapeutics, Inc., filed with California Secretary of State — bizfile Online.
The register reports 10 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Quince Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Quince Therapeutics, Inc. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 1 subsidiary spans United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Quince Therapeutics, Inc.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Quince Therapeutics, Inc.?
Three shareholders are currently on record for Quince Therapeutics, Inc., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 16.9% — the largest recorded stake — followed by Adar1 Capital Management, LLC at 1.2%; the remaining 1 shareholder shown holds smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is Quince Therapeutics, Inc.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for Quince Therapeutics, Inc. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does Quince Therapeutics, Inc. have on record?
3 shareholders are shown on record for Quince Therapeutics, Inc..
What is Quince Therapeutics, Inc.'s company registration number?
Quince Therapeutics, Inc.'s registration number is 5173483, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is inactive.
Is Quince Therapeutics, Inc. still an active company?
Quince Therapeutics, Inc.'s status on California Secretary of State — bizfile Online is listed as inactive, not currently active.
When was Quince Therapeutics, Inc. incorporated?
Quince Therapeutics, Inc. was incorporated on 26 July 2022, according to California Secretary of State — bizfile Online.
What is Quince Therapeutics, Inc.'s registered address?
The registered address on file for Quince Therapeutics, Inc. is United States.
Who are the officers/directors of Quince Therapeutics, Inc.?
The Ceo, Chief Medical Officer & Director of Quince Therapeutics, Inc. currently on record is Dirk Thye M.d.; five officers are currently on record for Quince Therapeutics, Inc., filed with California Secretary of State — bizfile Online. Management authority at Quince Therapeutics, Inc. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Quince Therapeutics, Inc. have a parent company or subsidiaries?
Quince Therapeutics, Inc. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 1 jurisdiction. Those 1 subsidiary spans United States jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to Quince Therapeutics, Inc.'s ownership over time?
This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to Quince Therapeutics, Inc.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Quince Therapeutics, Inc.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like Quince Therapeutics, Inc.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 6 October 2026.